Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Based on typical trial durations in this drug class (36+ weeks, plus enrollment and analysis time), a reasonable estimate puts the first Phase 3 diabetes readout sometime in 2027 though Novo Nordisk hasn't published a specific date, so this is an informed projection rather than a confirmed timeline
Most side effects from this injectable weightmanagement medication are gastrointestinal, mild to moderate, and temporarypeaking early and resolving within a few weeks
Most people need a short course of sessions spaced about four to six weeks apart, with results building over weeks
In contrast, methylcobalamin and adenosylcobalamin are already in active states, allowing for immediate cellular use
